![PRD_000725 PRD_000725](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000725.svg) | PRD_000725 | Name: | PYOVERDIN R Fe Complex | Formula: | C48 H64 Fe N15 O21 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000726 PRD_000726](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000726.svg) | PRD_000726 | Name: | PYOVERDIN 13525 Fe Complex | Formula: | C49 H71 Fe N14 O19 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000728 PRD_000728](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000728.svg) | PRD_000728 | Name: | Synthetic PYOVERDINE Fe Complex | Formula: | C56 H81 Fe N17 O24 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000734 PRD_000734](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000734.svg) | PRD_000734 | Name: | ALL-D KALATA B1 | Formula: | C117 H180 N35 O39 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_000749 PRD_000749](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000749.svg) | PRD_000749 | Name: | KALATA B1 | Formula: | C117 H180 N35 O39 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_000750 PRD_000750](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000750.svg) | PRD_000750 | Name: | CYCLIC KNOTTIN TRYPSIN INHIBITOR II | Formula: | C138 H229 N47 O45 S6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000752 PRD_000752](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000752.svg) | PRD_000752 | Name: | CIRCULIN A | Formula: | C134 H211 N38 O38 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
![PRD_000754 PRD_000754](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000754.svg) | PRD_000754 | Name: | PSEUDO-IODOTYROSTATIN | Formula: | C23 H27 I N2 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000755 PRD_000755](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000755.svg) | PRD_000755 | Name: | BOC ALA ALA PRO PVA | Formula: | C20 H37 N4 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000756 PRD_000756](https://data.pdbj.org/pdbjplus/data/cc/svg/0H8.svg) | PRD_000756 | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1R)-5-amino-1-phosphonopentyl]-L-prolinamide | Formula: | C19 H35 N4 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000758 PRD_000758](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000758.svg) | PRD_000758 | Name: | THIOPEPTIDE THIOSTREPTON REDUCED AT N-CA BOND OF RESIDUE 14 | Formula: | C72 H86 N19 O18 S5 | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES, ONE THIOZOLINE,
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 14 WAS CHEMICALLY MODIFIED TO
HAVE A SINGLE BOND N-CA. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000759 PRD_000759](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000759.svg) | PRD_000759 | Name: | THIOPEPTIDE THIOSTREPTON WITH EPIMER FORM OF RESIDUE 9 | Formula: | C69 H81 N18 O17 S5 | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED
FROM D-CYS TO L-CYS AND RESIDUE 17 (HET DHA)
WAS DELETED. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000760 PRD_000760](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000760.svg) | PRD_000760 | Name: | THIOPEPTIDE THIOSTREPTON OXIDIZED AT CA-CB BOND OF RESIDUE 9 | Formula: | C69 H79 N18 O17 S5 | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE LINKED TO MAIN-CHAIN
RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED: THE
CA-CB BOND WAS OXIDIZED FROM SINGLE TO DOUBLE.
RESIDUE 17 (HET DHA) WAS DELETED. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000762 PRD_000762](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000762.svg) | PRD_000762 | Name: | METHANOBACTIN MB-OB3B | Formula: | C45 H56 Cu N10 O16 S5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000764 PRD_000764](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000764.svg) | PRD_000764 | Name: | CYCLOSPORIN D, 5,7 mutation | Formula: | C64 H117 N11 O12 S | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED IN DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL).
THE CYCLOSPORIN D MOLECULE WAS MODIFIED AT
POSITIONS 5 AND 7 TO BE
(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE AND
(2-S-METHYL)-SARCOSINE, RESPECTIVELY. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000765 PRD_000765](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000765.svg) | PRD_000765 | Name: | CYCLOSPORIN A, 5 mutation | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000766 PRD_000766](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000766.svg) | PRD_000766 | Name: | CYCLOSPORIN A, 6 mutation | Formula: | C63 H113 N11 O13 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000767 PRD_000767](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000767.svg) | PRD_000767 | Name: | CYCLOSPORIN A, 7 mutation | Formula: | C63 H113 N11 O13 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000768 PRD_000768](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000768.svg) | PRD_000768 | Name: | CYCLOSPORIN A, 8 mutation | Formula: | C62 H111 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000769 PRD_000769](https://data.pdbj.org/pdbjplus/data/cc/svg/0KV.svg) | PRD_000769 | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3S)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | Formula: | C23 H34 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_002426 PRD_002426](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002426.svg) | PRD_002426 | Name: | Corramycin | Formula: | C51 H81 N11 O21 | Definition date: | 2023-08-16 | Last modified: | 2023-08-16 |
|
![PRD_002432 PRD_002432](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002432.svg) | PRD_002432 | Name: | Pam3-SKKKK | Formula: | C81 H160 N10 O13 S | Definition date: | 2023-07-12 | Last modified: | 2023-07-12 |
|
![PRD_002528 PRD_002528](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002528.svg) | PRD_002528 | Name: | 142D6 | Formula: | C26 H37 F N4 O6 S | Description: | Lys-covalent pan-IAP inhibitor | Definition date: | 2023-07-12 | Last modified: | 2023-07-12 |
|
![PRD_002527 PRD_002527](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002527.svg) | PRD_002527 | Name: | Intermediate for maxamycins synthesis | Formula: | C84 H114 Cl2 N8 O17 S Si2 | Definition date: | 2023-07-05 | Last modified: | 2023-07-05 |
|
![PRD_002431 PRD_002431](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002431.svg) | PRD_002431 | Name: | Cyclic tetraadenosine monophosphate (cA4) | Formula: | C40 H48 N20 O24 P4 | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | Definition date: | 2023-07-12 | Last modified: | 2023-07-03 |
|